Eyetech says stock halted before FDA panel meets
613863
Eyetech Pharmaceuticals Inc. (EYET.O: Quote, Profile, Research) said trading in its common stock was halted on Friday before a US advisory panel meets to review its experimental drug to stop vision loss in elderly patients.
618340
Ultimate Electronics Inc. on Tuesday said it was at risk of being delisted from the Nasdaq because of a delay in filing its results for the quarter ended Oct. 31.
741487
Japan&#39;s NEC Corp. said Wednesday that the New York-based Nasdaq stock exchange will suspend trading in its shares after it failed to meet a deadline to restate its past financial results.
251018
Linux supplier Lindows has announced it has called a halt to the initial public offering of its common stock after filing for registration in April.
210977
NEW YORK (CBS.MW) -- Shares of biotechnology company Eyetech Pharmaceuticals fell in after-hours trading Friday after a key US Food and Drug Administration advisory panel withheld approval for Macugen, a new drug to treat failing eyesight in the elderly.
308611
Investors dumped shares of Pfizer Inc. today in response to the drug giant's weekend announcement that it has halted development of a potential blockbuster cholesterol treatment.
367582
U.S. regulators on Friday delayed a decision on whether to approve over-the-counter sales of a Barr Pharmaceuticals "morning-after pill" to prevent pregnancy, prompting a lawsuit from a women's rights group.
572692
Trading in shares of Swedish health care company Gambro AB were halted Monday by the Stockholm Stock Exchange following a report that the US dialysis company DaVita Inc.
301805
Trading in shares of China Pharmaceutical Group Ltd.  was suspended on Monday, pending an announcement on a possible mandatory unconditional general offer, the Hong Kong exchange said.
577773
GenVec Inc. shares lost almost half their value Thursday after the Food and Drug Administration halted a study of its lead product candidate because the anti-cancer drug may increase blood clots in patients.
526924
Momenta announces a delay in the FDA review of its lead drug.
233864
Eyetech Pharmaceuticals (EYET:Nasdaq - news - research) faces an important regulatory test Aug. 27 when a Food and Drug Administration advisory panel will review Macugen, the company&#39;s experimental drug intended
609900
Shares in Cambridge Antibody Technology will be suspended on Monday morning until the High Court in London rules on a royalty dispute that could radically affect the fortunes of the biotechnology company.
380722
By CARRIE JOHNSON  WASHINGTON - Securities regulators halted trading in nearly three dozen companies - the initial salvo in "Operation Spamalot," a campaign to block e-mails promoting stocks to unsuspecting investors.
262708
Discovery Laboratories Inc. said on Tuesday the expected launch of its experimental respiratory treatment for premature infants will be delayed until the fourth quarter after U.S. regulators found quality-control problems in its manufacturing.
57805
The Securities and Exchange Commission suspended trading on Thursday in the stocks of 35 small companies linked to spam e-mail campaigns urging small investors to buy shares.
506795
The New York Stock Exchange halted trading in Lear shares at 10:41 a.m. Trading did not resume.